Reply by Authors

Affiliations

¹ Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
² Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
³ Connected Health Applications & Interventions (CHAI) Core, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
⁴ Center for Health Promotion and Disease Prevention, UNC at Chapel Hill, Chapel Hill, North Carolina.
⁵ Bladder Cancer Advocacy Network, Bethesda, Maryland.
⁶ University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.

Comment

Taylor Parisse et al. J Urol. 2023 Jan.

. 2023 Jan;209(1):160.

doi: 10.1097/JU.0000000000002941.03. Epub 2022 Oct 10.

¹ Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
² Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
³ Connected Health Applications & Interventions (CHAI) Core, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
⁴ Center for Health Promotion and Disease Prevention, UNC at Chapel Hill, Chapel Hill, North Carolina.
⁵ Bladder Cancer Advocacy Network, Bethesda, Maryland.
⁶ University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.

No abstract available

Comment on

Editorial Comment.
Dullea AD, Hougen HY. Dullea AD, et al. J Urol. 2023 Jan;209(1):159. doi: 10.1097/JU.0000000000002941.01. Epub 2022 Oct 10. J Urol. 2023. PMID: 36215699 No abstract available.
Editorial Comment.
Finney EL, Stensland KD, Zaid HB. Finney EL, et al. J Urol. 2023 Jan;209(1):159-160. doi: 10.1097/JU.0000000000002941.02. Epub 2022 Oct 10. J Urol. 2023. PMID: 36215700 No abstract available.